Generating systemic change along the addiction recovery continuum

kasey claborn

New Research Study from ARI Director – PREP Interests, Barriers, and Interventions

October 26, 2023

A new study, co-written by ARI Director, Dr. Kasey Claborn explores how PREP — Pre-exposure prophylaxis — can be used to help contracting HIV. In their findings, Dr. Claborn et al find that PreP adoption among women is low.

TxCOPE in the News – Dallas Morning News Fentanyl Series

September 26, 2023

In a new feature from The Dallas Morning News, TxCOPE's lead researcher Dr. Kasey Claborn was quoted in her efforts to help bring TxCOPE's mission across Texas, serving as a front-runner in overdose data tracking which helps overdose prevention agencies report and track overdoses in their community.

New paper published by ARI associates, leadership and community professionals

July 7, 2023

On June 9th, the Harm Reduction Journal published a new paper from various TxCOPE researchers along with addiction professionals on best practices in harm reduction. ARI research associates conducted a qualitative study with N=69 #HarmReduction workers, first responders, and PWUD in Texas…